São Paulo, August 13, 2026 – Eurofarma has achieved, for the fifth consecutive year, first place among pharmaceutical companies in the Great Place to Work (GPTW) Latin America Best Workplaces ranking. The recognition highlights the consistency of the company's organizational culture and its ongoing commitment to fostering an environment built on trust, respect, and collaboration. Eurofarma also ranked 8th among all companies participating in the ranking.

Eurofarma's international journey began in 2009 with the acquisition of its operation in Argentina. Since then, the company has expanded its regional presence and is now active in 24 countries, pursuing its purpose of helping people live longer and healthier lives. This commitment is also reflected in the way the company cares for its employees, encouraging professional development, innovation, and the creation of positive impact across all the markets where it operates.

Achieving first place for five consecutive years demonstrates the strength of a culture that transcends borders and connects different realities through shared values. This achievement is the result of the contributions of employees throughout Latin America, who help strengthen a workplace environment characterized by a sense of belonging, growth, and mutual trust.

To learn more about Eurofarma's initiatives focused on its people and culture, visit: Sustainability Integrated Report

About Eurofarma

Founded in 1972, Eurofarma operates in the healthcare sector through the production and commercialization of products and services aimed at improving people's quality of life. Focused on generating shared value, the company covers the main pharmaceutical segments, including prescription medicines, generics, hospital products, oncology, OTC medicines, personal care, and animal health, as well as providing contract manufacturing services. With broad coverage across therapeutic classes, its portfolio includes more than 4,000 SKUs, serving virtually all medical specialties. A leader in prescription medicines in Brazil, where it also holds the second position in generics, Eurofarma is present in 24 countries, with 100% coverage across Latin America and leadership in the region’s retail market. The company also maintains operations in the United States and Africa, employing more than 13,000 people and operating 10 manufacturing plants. In 2025, it produced 630 million units. In the same year, Eurofarma invested more than BRL 700 million in innovation projects and achieved net revenue exceeding BRL 12 billion.